Angus C. Russell - 29 Jun 2021 Form 4 Insider Report for Lineage Cell Therapeutics, Inc. (LCTX)

Role
Director
Signature
/s/ Grant Harbert, as Attorney-in-Fact
Issuer symbol
LCTX
Transactions as of
29 Jun 2021
Transactions value $
$40,366
Form type
4
Filing time
30 Jun 2021, 18:58:12 UTC
Previous filing
07 May 2021
Next filing
02 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LCTX Common Shares, no par value Options Exercise $54.4K +24.7K +36.62% $2.20 92.2K 29 Jun 2021 Direct
transaction LCTX Common Shares, no par value Sale -$14K -4.72K -5.12% $2.97 87.5K 29 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LCTX Stock Option (right to buy) Options Exercise $0 -24.7K -100% $0.00* 0 29 Jun 2021 Common Shares 24.7K $2.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option became exercisable in four equal quarterly installments after the date of grant on July 1, 2016.

Remarks:

Exhibit 24.1 - Substitute Power of Attorney